Pure Global AI
Poland flag

Poland medical device registration timeline

Source-linked clocks

Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL) review clocks and end-to-end planning ranges, using the 4-class (I, IIa, IIb, III) — EU MDR classification system.

1 pathways1 of 1 clocks verifiedvalidity 5 years (CE certificate)MDSAP not acceptedreviewed 2026-08-29eur-lex.europa.eu
Class / pathwayReview clockPlanning totalWith prior approvalProvenance
Class I(Self-declaration (no notified body))
MDR Art. 52(7): non-sterile, non-measuring, non-reusable-surgical Class I devices are self-declared, so no authority or notified body reviews the file and there is no review clock
0 days6-9 monthsVerified
Review clocks exclude applicant hold time · planning totals are estimates

Poland Medical Device Registration Process

Step-by-step URPL registration process. Total estimated timeline: 6-9 months.

Step 1: Pre-Submission Preparation

1-3 months

Gather technical documentation, quality management system (QMS) records, and clinical data required by URPL. Appoint a EU Authorized Representative.

Step 2: Application Submission

1-2 weeks

Submit complete registration dossier to URPL including device description, risk analysis, and testing reports.

Step 3: Administrative Review

2-4 weeks

URPL reviews application for completeness. May request additional documents or clarifications.

Step 4: Technical Evaluation

0 days

In-depth technical assessment of device safety and performance. URPL may issue questions.

Step 5: Registration Approval

1-2 weeks

Upon successful review, URPL issues Poland market authorization certificate.

Summary: The Poland medical device registration process through Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL) consists of 5 main steps: Pre-Submission Preparation → Application Submission → Administrative Review → Technical Evaluation → Registration Approval.
Prior approval recognition
FDA 510(k)/PMANo substitute for EU MDR conformity assessment; useful as predicate documentation in the technical file
Key requirements
  • EU Authorized Representative (for non-EU manufacturers)
  • Clinical investigation Art. 70: validation + 45-day assessment; substantial modification Art. 75: validation + 38 days; extensions +20/+7 (Art. 34 Ustawy o wyrobach medycznych)
  • Bioethics opinion within 45 days (Art. 31(2)); IVDR Art. 66(2): validation + 45 days (Art. 42)
  • Free-sale certificate within 15 working days (Art. 30); register entries within 7 days of a complete application and updates within 7 days of a change (Arts. 20, 25)
  • Legacy notification completion: 14/30 days (Art. 139(11))
Primary regulator sources

Reviewed 2026-08-29. End-to-end totals remain planning estimates.

Keep researching this market
View the Poland resource hub →
Compare timeline across all countries →
Source-linked review clocks verified against URPL publications · full review 2026-08-29 · row IDs are stable — cite as registration-timeline:poland:class-i